Rhone Ma Holdings BhdXKLS:5278 61 ROE % is 7.71% as of Mar. 2026, which is 10% below its 10-year median of 8.54. GuruFocus rates XKLS:5278 with a GF Score™ of 61/100 and a GF Value™ of RM0.80 (Modestly Undervalued). Among 935 Drug Manufacturers companies, Rhone Ma Holdings Bhd ranks better than 57.65% on this metric.
The historical rank and industry rank for Rhone Ma Holdings Bhd's ROE % or its related term are showing as below:
XKLS:5278'
s ROE % Range Over the Past 10 Years
Min: 6.3 Med: 8.54 Max: 14.07
Current: 8.14
During the past 13 years, Rhone Ma Holdings Bhd's highest ROE % was 14.07%. The lowest was 6.30%. And the median was 8.54%.
XKLS:5278's ROE % is ranked better than 57.65% of 935
companies
in the Drug Manufacturers industry
Industry Median: 6
vs XKLS:5278: 8.14
Rhone Ma Holdings Bhd (XKLS:5278) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Rhone Ma Holdings Bhd's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhone Ma Holdings Bhd ROE % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rhone Ma Holdings Bhd's ROE % distribution charts can be found below:
* The bar in red indicates where Rhone Ma Holdings Bhd's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Rhone Ma Holdings Bhd (XKLS:5278) has a ROE % of 7.71% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Rhone Ma Holdings Bhd and its competitors. This is 10% below median its historical median of 8.54. Over the past decade, Rhone Ma Holdings Bhd's ROE % has ranged from 6.30 to 14.07. According to the industry distribution chart, Rhone Ma Holdings Bhd ranks #396 out of 935 companies in the Drug Manufacturers industry, placing it in the top 42.4%.
Is Rhone Ma Holdings Bhd's ROE % too high?
Rhone Ma Holdings Bhd's current ROE % of 7.71% is 10% below median its 10-year median of 8.54. Over the past 10 years, this metric has ranged from a low of 6.30 to a high of 14.07. The Drug Manufacturers industry median ROE % is 6.00. Rhone Ma Holdings Bhd's value of 7.71% is 28.5% above this industry median. Based on the distribution chart, Rhone Ma Holdings Bhd ranks #396 out of 935 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Rhone Ma Holdings Bhd has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rhone Ma Holdings Bhd's ROE % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Rhone Ma Holdings Bhd ranks #396 out of 935 companies for ROE %. This puts Rhone Ma Holdings Bhd in the upper half of its industry. The industry median ROE % is 6.00. Rhone Ma Holdings Bhd's value of 7.71% is 28.5% above this benchmark. Historically, Rhone Ma Holdings Bhd's own ROE % has ranged from 6.30 to 14.07 over the past decade. While the company's 10-year median is 8.54 vs. the industry median of 6.00, Rhone Ma Holdings Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Drug Manufacturers company?
The median ROE % among Drug Manufacturers companies is 6.00, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rhone Ma Holdings Bhd's current ROE % of 7.71% is 28.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Rhone Ma Holdings Bhd and its competitors. For the Drug Manufacturers industry, the median ROE % is 6.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhone Ma Holdings Bhd's current ROE % is 7.71%, which is 10% below median its own 10-year median of 8.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhone Ma Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Rhone Ma Holdings Bhd (XKLS:5278) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.80, compared to a current price of RM0.69 — trading 13.8% below its estimated fair value. The current ROE % is 7.71%, which is 10% below median its 10-year median of 8.54 and 28.5% above the Drug Manufacturers industry median of 6.00. Rhone Ma Holdings Bhd's overall GF Score™ is 61/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Rhone Ma Holdings Bhd (XKLS:5278), the current ROE % is 7.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rhone Ma Holdings Bhd (XKLS:5278) Overvalued in 2026?
Based on GuruFocus' analysis, Rhone Ma Holdings Bhd stock appears to be undervalued.
The current stock price of RM0.69 is trading 13.8% below its estimated GF Value™ of RM0.80.
GuruFocus considers Rhone Ma Holdings Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:5278:
ROE %: 7.71% (10% below median its 10-year median of 8.54)
GF Value™: RM0.80 vs. price of RM0.69 (13.8% below fair value)
Industry Position: 28.5% above the Drug Manufacturers median (#396 of 935)
No single metric tells the full story. See the XKLS:5278 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rhone Ma Holdings Bhd, along with its subsidiaries, is mainly involved in the provision of end-to-end animal health solutions. The Group provides veterinary consultation services, diagnostic laboratory analyses, R&D, and is engaged in the manufacturing and distribution of animal health products. Its reportable segments are: Animal health products and equipment, Food ingredients, and Others. The majority of its revenue is generated from the Animal health products and equipment segment, which is engaged in marketing, trading, distribution, and manufacturing of animal health products and equipment, such as pharmaceuticals, vaccines, feed additives, pesticides, and others. Geographically, the Group's operations are predominantly located in Malaysia.
61GF Score
Get the complete analysis for XKLS:5278
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5278 has been successfully added to your 
